- Mywell Technology rises nearly 4% in pre-market trading amid reports of a $115 billion acquisition of Lumentum.
- XRPL AI records nearly 15 million payments, but settlement total remains under $50,000
- The transaction between Mywell Technology and Lumentum is expected to be completed in the first half of 2028.
- Maivell Technology and Lumentum to merge to create a leading AI connectivity company
- CHURCH & DWIGHT CO INC <CHD.N>: RAYMOND JAMES RAISES TARGET PRICE TO $115 FROM $112
- CENTERRA GOLD INC. <CG.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$32 FROM C$29
- Lumentum reported adjusted earnings per share of $4.57 for the first fiscal quarter, exceeding the market estimate of $4.21; it expects net revenue for the second fiscal quarter to be between $1.58 billion and $1.63 billion, higher than the market estimate of $1.48 billion.
- Correct: Capital Power 3Q EPS C$0.37 >CPX.T
- NASDAQ TRADE HALT <DRUG.O> HALT NEWS PENDING AT 07:25 AM
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 07:25 AM
- MAPLEBEAR INC. <CART.O>: CITIGROUP RAISES TARGET PRICE TO $65 FROM $58
- IMPERIAL OIL <IMO.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$145 FROM C$140
- APTARGROUP, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $160 FROM $155
- METHANEX CORPORATION <MEOH.O>: RAYMOND JAMES RAISES TARGET PRICE TO $80 FROM $72
- PRIMIS FINANCIAL CORP <FRST.O>: RAYMOND JAMES CUTS TARGET PRICE TO $17 FROM $18
- Market Cap Surges by $1 Trillion in Nearly Four Months, 36x P/E Ratio Hits Highest Since 2008: Apple (AAPL.US) Earnings Leave No Room for Disappointment
- PERMIAN RESOURCES CORPORATION : RAYMOND JAMES RAISES TARGET PRICE TO $34 FROM $29
- Market capitalization has surged by $1 trillion in nearly four months, with a price-to-earnings ratio of 36 times hitting the highest level since 2008: Apple's (AAPL.US) earnings report leaves no room for disappointment.
- Deutsche Bank raises Microsoft target price to $620
- Tower Semiconductor expects fourth-quarter revenue of $600 million, higher than expected
- Deutsche Bank Adjusts Target Prices for Pinterest and Roblox
- Xcel Energy plans to issue $2.0 billions in convertible senior notes maturing in 2027
- ARTHUR J. GALLAGHER & CO. : CITIGROUP CUTS TO NEUTRAL FROM BUY; RAISES TARGET PRICE TO $300 FROM $285
- FIRST BUSINESS FINANCIAL SERVICES INC <FBIZ.O>: RAYMOND JAMES RAISES TARGET PRICE TO $83 FROM $75
- FIRST MID BANCSHARES INC <FMBH.O>: RAYMOND JAMES RAISES TARGET PRICE TO $57 FROM $56
- UniCredit partners with ICICI Bank to support Europe-India trade and investment
- REPUBLIC SERVICES INC <RSG.N>: CITIGROUP RAISES TARGET PRICE TO $281 FROM $259
- MOHAWK INDUSTRIES, INC. <MHK.N>: RAYMOND JAMES RAISES TARGET PRICE TO $160 FROM $145
- Handelsbanken holds 5.13% of Netcompany voting rights
- REGENERON PHARMACEUTICALS, INC. <REGN.O>: CITIGROUP RAISES TARGET PRICE TO $825 FROM $740
- M Cash Integrasi Total Liabilities Rise 26.6% to Rp 948.02 Billion at End-September
- GENERAL DYNAMICS CORP <GD.N>: CITIGROUP RAISES TARGET PRICE TO $400 FROM $374
- Leonardo schedules shareholder meeting
- ABBVIE : CITIGROUP RAISES TARGET PRICE TO $295 FROM $260
- PORTLAND GENERAL ELECTRIC CO : BMO CUTS TARGET PRICE TO $47 FROM $48
- XCEL ENERGY <XEL.O>: BMO RAISES TARGET PRICE TO $90 FROM $87
- Alamtri Minerals Confirms Thohir, Subianto, Rachmat Families and Edwin Soeryadjaya as Ultimate Controllers
- Capital Power management commentary cites stronger PJM prices, summer demand as drivers of Q3 2026 adjusted EBITDA growth
- WEST FRASER TIMBER CO. LTD. <WFG.N>: BMO CUTS TARGET PRICE TO $87 FROM $90
- Alamtri Clarifies Thohir, Subianto, Rachmat Families and Edwin Soeryadjaya Are Ultimate Controllers
- TransDigm Group publishes update to financial calendar
- EQUINIX, INC. <EQIX.O>: BMO RAISES TARGET PRICE TO $1250 FROM $1225
- SS&C Launches $500 Million Incremental Term Loan Syndication
- Atlas One Capital Signs Definitive Agreement to Acquire Ramsden Metals
- Goldsky Resources appoints Teemu Törmälehto as Nordic exploration manager
- AECON GROUP INC. : STIFEL RAISES TARGET PRICE TO C$75 FROM C$66
- TOROMONT INDUSTRIES LTD <TIH.TO>: RBC CUTS TARGET PRICE TO C$261 FROM C$265
- ADC Therapeutics Sets Third-Quarter Financial Results Release
- Emira Property Fund sets R 200 million debt repayment for November 24
- Marvell Technology: Maintaining Midpoint of Its Prior Rev Guidance While Narrowing Expected Range to Plus or Minus 2%, Vs Original Range of Plus or Minus 5% >MRVL
- WELLTOWER INC. <WELL.N>: BMO RAISES TARGET PRICE TO $270 FROM $265
- APPLIED OPTOELECTRONICS, INC. : NORTHLAND CAPITAL RAISES TO OUTPERFORM FROM MARKET PERFORM
- VENTAS, INC. <VTR.N>: BMO CUTS TARGET PRICE TO $100 FROM $107
- COHERENT CORP. <COHR.N>: NORTHLAND CAPITAL RAISES TO OUTPERFORM FROM MARKET PERFORM
- Marvell Technology: Reports Preliminary Rev for 3Q of Fiscal 2027 Consistent With Previously Provided Guidance >MRVL
- FEDERAL REALTY INVESTMENT TRUST <FRT.N>: BMO CUTS TARGET PRICE TO $130 FROM $135
- EXELON CORP <EXC.O>: BMO RAISES TARGET PRICE TO $47 FROM $45
- Marvell Technology, Lumentum: Current Marvell Stockholders Will Own About 67% of Combined Co While Lumentum Stockholders Will Own About 33% >MRVL
- Marvell Technology, Lumentum: Following Closing, Matt Murphy Will Continue as Chmn and CEO of Combined Co >MRVL
- Marvell Technology, Lumentum: Transaction Expected to Close in the 1H of Calendar Yr 2028 >MRVL
- ALLIANT ENERGY CORP <LNT.O>: BMO RAISES TARGET PRICE TO $79 FROM $76
- CHENIERE ENERGY, INC. <LNG.N>: BMO RAISES TARGET PRICE TO $350 FROM $306
- Marvell Technology, Lumentum: Transaction Has an Implied Enterprise Value of $115B for Lumentum >MRVL
- Karyopharm Therapeutics: Ayrmid Will Serve as Lead Bidder in Court-Supervised Sale Process >KPTI
- Marvell Technology, Lumentum: Lumentum Stockholders Will Receive a Fixed Exchange Ratio of 4.500 Shrs of Marvell Common Stk for Each Shr of Lumentum Common Stk They Own >MRVL
- REGENERON PHARMACEUTICALS, INC. <REGN.O>: BMO RAISES TARGET PRICE TO $1050 FROM $920
- Karyopharm files for Chapter 11 to pursue Ayrmid merger
- Japan Lifeline Publishes Transcript of FY2027 Q2 Financial Results Briefing
- ABBVIE : BMO RAISES TARGET PRICE TO $340 FROM $300
- Karyopharm Therapeutics: Remains Focused on Supporting Patients and Advancing Its Programs in Multiple Myeloma and Myelofibrosis >KPTI
- Karyopharm Therapeutics Inc. Announces Planned Merger With Ayrmid Ltd. To Strengthen Company For The Future >KPTI
- BRIEF-Equinor CEO says European gas storage levels at lowest in 15 years
- Marriott Sees 4Q Adj EPS $3.14-Adj EPS $3.21 >MAR
- Marriott 3Q EPS $3.04 >MAR
- Chorus Aviation Completes The Acquisition Of SkyCare Air Ambulance >CHR.T
- Axsome Therapeutics 3Q Loss/Shr 25c >AXSM
- Lumentum Holdings Sees 2Q Adj EPS $5.90-Adj EPS $6.20 >LITE
- Lumentum Holdings 1Q Adj EPS $4.57 >LITE
- Lumentum Holdings 1Q EPS $3.54 >LITE
- Lumentum Holdings Sees 2Q Rev $1.58B-$1.63B >LITE
- Marriott 3Q Rev $7.01B >MAR
- Marriott Sees FY Adj EPS $12.07-Adj EPS $12.14 >MAR
- Marriott 3Q Comparable System-Wide Intl Constant Dollar RevPAR Up 4.4% >MAR
- Marriott 3Q Comparable System-Wide U.S. & Canada Constant Dollar RevPAR Up 7.4% >MAR
- Marriott 3Q Comparable System-Wide Worldwide Constant Dollar RevPAR Up 6.5% >MAR
- SUNation Energy Announces Confidential Submission Of Draft Registration Statement On Form S-4 In Connection With Proposed Merger With Suniva >SUNE
- --Deutsche Bank Adjusts Federated Hermes Price Target to $60 From $62, Maintains Hold Rating
- --Guggenheim Initiates Retension Pharmaceuticals at Buy With $55 Price Target
- Marriott International's Q3 Adjusted Earnings, Revenue Rise
- Cipher Digital Q3 Loss Widens, Revenue Falls
- Eton Pharmaceuticals Starts New Program to Evaluate Mecasermin in Treating Spasms
- Matador's San Mateo Signs Delaware Basin Gas Deals
- Deutsche Bank Adjusts Lear Price Target to $121 From $122, Maintains Hold Rating
- --Deutsche Bank Adjusts Garrett Motion Price Target to $30 From $32, Maintains Buy Rating
- Tower Semiconductor's Q3 Adjusted Earnings, Revenue Rise; Provides Q4 Revenue Guidance
- Axsome Therapeutics Q3 Loss Narrows, Revenue Increases - Shares Up Pre-Bell
- GeoPark's Venezuela Production Participation Contract Takes Effect
- Krystal Biotech Q3 Net Income Falls, Revenue Rises; Shares Up Pre-Bell
- Pecoy Copper to Raise CA$49.8 Million Via Private Placement Led by Hudbay Minerals
- --HC Wainwright Upgrades Inovio Pharmaceuticals to Buy From Neutral, Price Target is $5
